Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-08 11:28 am Purchase | 2026-06-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | T. Rowe Price Associates, Inc. | 8,861,282 10.500% | 4,224,222 (+91.10%) | Filing History |
| 2026-07-06 5:51 pm Sale | 2026-07-01 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | New Enterprise Associates 17, L.P. | 6,692,298 7.900% | -1,104,732 (-14.17%) | Filing History |
| 2026-05-15 4:24 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | TCG Crossover GP II, LLC | 4,622,151 5.500% | 194,446 (+4.39%) | Filing History |
| 2026-05-15 4:18 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Baker Bros. Advisors LP | 8,876,346 9.990% | 4,530,610 (+104.25%) | Filing History |
| 2026-05-15 4:10 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 5,085,886 6.300% | 1,250,000 (+32.59%) | Filing History |
| 2026-04-22 5:40 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Adam Goulburn | 6,513,765 8.100% | 850,500 (+15.02%) | Filing History |
| 2026-03-19 4:05 pm Purchase | 2026-03-17 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | New Enterprise Associates 17, L.P. | 7,797,030 9.700% | 22,100 (+0.28%) | Filing History |
| 2026-02-17 4:14 pm Sale | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 3,835,886 5.900% | -1,824,246 (-32.23%) | Filing History |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Baker Bros. Advisors LP | 4,345,736 6.700% | -570,359 (-11.60%) | Filing History |
| 2026-01-21 11:59 am Purchase | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Adam Goulburn | 5,663,265 8.700% | 905,702 (+19.04%) | Filing History |
| 2026-01-09 4:19 pm Sale | 2026-01-07 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI, L.P. | 2,236,708 3.400% | -1,097,961 (-32.93%) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | T. Rowe Price Associates, Inc. | 4,637,060 7.500% | -1,964,081 (-29.75%) | Filing History |
| 2025-11-14 09:07 am Sale | 2025-09-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 0 0.000% | -3,725,000 (Position Closed) | Filing History |
| 2025-11-12 4:13 pm Sale | 2025-11-10 | 13D | MONTE ROSA THERAPEUTICS INC CO GLUE | Versant Venture Capital VI, L.P. | 3,334,669 5.100% | -744,800 (-18.26%) | Filing History |
| 2025-10-31 11:04 am Sale | 2025-09-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | VANGUARD GROUP INC | 2,988,953 4.830% | -167,401 (-5.30%) | Filing History |
| 2025-10-17 4:29 pm Purchase | 2025-10-10 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | TCG Crossover GP II, LLC | 4,427,705 7.200% | 4,427,705 (New Position) | Filing History |
| 2025-10-03 12:19 pm Purchase | 2024-05-16 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Adam Goulburn | 4,757,563 7.700% | 4,757,563 (New Position) | Filing History |
| 2025-08-14 07:10 am Sale | 2025-06-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 3,725,000 6.100% | -620,000 (-14.27%) | Filing History |
| 2025-06-06 10:03 am Sale | 2025-05-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | FMR LLC | 1,750,731 2.800% | -3,350,682 (-65.68%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 5,660,132 9.200% | 1,266,922 (+28.84%) | Filing History |